| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0e9a12cf014183b1163d45822bf4a3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14a56e82e7ee8111cfcd7565412176b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34f70f5670a1e2551571332aa61f59a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7c7ffd2fa0c599de7164aea70b7c9f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7706bcb64a3ca309f02399b7e0d62358
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f7e8d5e5fb88c674d017aa2379fc97a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate |
2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c22c0b910de13bce9641859dbe22e920
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_febc4c9796aaa5cc0b49355d702281de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b69afb5db725c509ae18287b179faa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc1de4d3f0f913fd5e1a59b5cee6999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df8e95b0a36c8788652e1b570575cfe7 |
| publicationDate |
2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10258580-B2 |
| titleOfInvention |
Cannabinoids for use in the treatment of neurodegenerative diseases or disorders |
| abstract |
The present invention relates to cannabinoids for use in the prevention or treatment of neurodegenerative diseases or disorders. Preferably the cannabinoids are cannabichromene (CBC) cannabidivarin (CBDV) and/or cannabidivarin acid (CBDVA). More preferably the neurodegenerative disease or disorder to be prevented or treated is Alzheimer's disease. |
| priorityDate |
2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |